Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Vitamin E539 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A28100 | 16424622 | Indian J Gastroenterol | Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease. | 2006 | Details |
A28112 | 16393299 | Aliment Pharmacol Ther | Review article: Drug therapy for non-alcoholic fatty liver disease. | 2006 | Details |
A28113 | 16393285 | Aliment Pharmacol Ther | Blood oxidative stress markers are unreliable markers of hepatic steatosis. | 2006 | Details |
A28165 | 16231594 | Eur Rev Med Pharmacol Sci | The treatment of NAFLD. | 2006 | Details |
A28238 | 15990709 | Minerva Gastroenterol Dietol | [Effects of a new pharmacological complex (silybin + vitamin-E + phospholipids) on some markers of the metabolic syndrome and of liver fibrosis in patients with hepatic steatosis. Preliminary study]. | 2005 | Details |
A28273 | 15842582 | Am J Gastroenterol | A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. | 2005 | Details |
A28319 | 15696851 | Scand J Gastroenterol Suppl | Non-alcoholic fatty liver disease: a brief review. | 2004 | Details |
A28339 | 15598336 | Pediatr Transplant | Non-alcoholic steatohepatitis in children. | 2004 | Details |
A28416 | 15114291 | Ann Hepatol | Treatment of nonalcoholic fatty liver disease. | 2004 | Details |
A28453 | 14613504 | Nutr J | Vitamin C and vitamin E in prevention of Nonalcoholic Fatty Liver Disease (NAFLD) in choline deficient diet fed rats. | 2003 | Details |
A28459 | 14585234 | Curr Treat Options Gastroenterol | Treatment of Nonalcoholic Fatty Liver Disease. | 2003 | Details |
A28510 | 12406443 | Best Pract Res Clin Gastroenterol | Steatohepatitis in children. | 2002 | Details |
A28519 | 12296456 | Nutr Rev | Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. | 2002 | Details |
A28520 | 12214335 | Rev Gastroenterol Mex | [Non-alcoholic steatohepatitis]. | 2002 | Details |
A28551 | 11564008 | Aliment Pharmacol Ther | Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. | 2001 | Details |
A28650 | 35183762 | Nanomedicine | Platelet-neutrophil hybrid membrane-coated gelatin nanoparticles for enhanced targeting ability and intelligent release in the treatment of non-alcoholic steatohepatitis. | 2022 | Details |
A28842 | 34919247 | Eur Rev Med Pharmacol Sci | A randomized controlled trial comparing the effects of Vitamin E, Ursodeoxycholic acid and Pentoxifylline on Egyptian non-alcoholic steatohepatitis patients. | 2021 | Details |
A30156 | 32882802 | Antioxidants (Basel) | Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation. | 2020 | Details |
A31304 | 30846912 | Gastroenterol Hepatol (N Y) | Pharmacologic Management of Nonalcoholic Steatohepatitis. | 2018 | Details |
A32658 | 27816611 | Free Radic Biol Med | Vitamin E: Emerging aspects and new directions. | 2016 | Details |
A32915 | 27095224 | Arch Biochem Biophys | The rise, the fall and the renaissance of vitamin E. | 2016 | Details |
A33505 | 25848483 | World J Hepatol | Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy. | 2015 | Details |
A34156 | 26202298 | Hepatol Int | Pharmacological agents for nonalcoholic steatohepatitis. | 2013 | Details |
A34410 | 23526264 | J Clin Biochem Nutr | Effects of tocotrienol on tumor necrosis factor-α/d-galactosamine-induced steatohepatitis in rats. | 2013 | Details |
A34532 | 24695939 | Hepat Med | Treatment of nonalcoholic steatohepatitis with vitamins E and C: a pilot study. | 2013 | Details |
A34549 | 23227320 | Hepat Res Treat | Antioxidant therapy in nonalcoholic steatohepatitis. | 2012 | Details |
A35001 | 22013536 | Int J Hepatol | NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA. | 2011 | Details |
A35196 | 21463986 | Eur J Med Res | Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH). | 2011 | Details |
A35530 | 20427778 | N Engl J Med | Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. | 2010 | Details |
A35709 | 19856260 | Exp Clin Endocrinol Diabetes | Chronic acetonemia alters liver oxidative balance and lipid content in rats. A model of NASH? | 2009 | Details |
A35822 | 19606393 | Scand J Gastroenterol | Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. | 2009 | Details |
A35865 | 19539747 | Free Radic Biol Med | Curcumin ameliorates rabbits's steatohepatitis via respiratory chain, oxidative stress, and TNF-alpha. | 2009 | Details |
A35915 | 19422479 | Liver Int | Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis. | 2009 | Details |
A36722 | 17388862 | Intern Med J | Effects of vitamin E treatment on peroxisome proliferator-activated receptor-alpha expression and insulin resistance in patients with non-alcoholic steatohepatitis: results of a pilot study. | 2007 | Details |
A36824 | 17162245 | Clin Gastroenterol Hepatol | Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis. | 2006 | Details |
A37322 | 15959406 | Ann Endocrinol (Paris) | [Nonalcoholic steatohepatitis]. | 2005 | Details |
A37403 | 15754789 | Lijec Vjesn | [Nonalcoholic steatohepatitis in children]. | 2005 | Details |
A37463 | 15625656 | Clin Gastroenterol Hepatol | A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. | 2004 | Details |
A37683 | 24672082 | Curr Ther Res Clin Exp | Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients. | 2004 | Details |
A37708 | 15066643 | Eur J Intern Med | Non-alcoholic steatohepatitis: review of a growing medical problem. | 2004 | Details |
A37795 | 14638353 | Am J Gastroenterol | Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. | 2003 | Details |
A37879 | 12883485 | Hepatology | Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. | 2003 | Details |
A38083 | 12197781 | Altern Med Rev | Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. | 2002 | Details |
A38085 | 12192203 | J Clin Gastroenterol | Management of nonalcoholic steatohepatitis: an analytic review. | 2002 | Details |
A38186 | 11944630 | Semin Gastrointest Dis | Diabetes mellitus, obesity, and hepatic steatosis. | 2002 | Details |
A38220 | 11873108 | J Clin Gastroenterol | Update on nonalcoholic fatty liver disease. | 2002 | Details |
A38591 | 10839868 | J Pediatr | Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. | 2000 | Details |
A42230 | 35158374 | Diabetes Care | Fructose Intake From Fruit Juice and Sugar-Sweetened Beverages Is Associated With Higher Intrahepatic Lipid Content: The Maastricht Study. | 2022 | Details |
A42418 | 34590125 | J Nutr | Diet and Liver Adiposity in Older Adults: The Multiethnic Cohort Adiposity Phenotype Study. | 2021 | Details |
A43378 | 31876593 | AIDS | Vitamin E as a 'bridge' therapy for nonalcoholic steatohepatits in HIV: what is waiting on the other side of the bridge? | 2020 | Details |
A43471 | 31628635 | Hormones (Athens) | Asporin levels are low in patients with nonalcoholic fatty liver disease and increase after vitamin E treatment. | 2019 | Details |
A43589 | 31341440 | Integr Med (Encinitas) | Barrie Tan, PhD: Using Tocotrienols to Address Lifestyle and Metabolic Disease. | 2019 | Details |
A43788 | 30883822 | Hepatology | Letter to the Editor: Will Vitamin E Be the Hope of Patients With NASH and Advanced Fibrosis? The Reliability Is Worth Discussing. | 2019 | Details |
A43798 | 30854668 | Hepatology | Reply. | 2019 | Details |
A43805 | 30835849 | J Food Sci | Extraction Technology Can Impose Influences on Peanut Oil Functional Quality: A Study to Investigate the Lipid Metabolism by Sprague-Dawley Rat Model. | 2019 | Details |
A43936 | 30417297 | Bull Exp Biol Med | Biochemical and Morphological Parameters of Inbred/Outbred Lines and DBCB Tetrahybrid Mouse in High-Sugar In Vivo Model of Metabolic Syndrome. | 2018 | Details |
A43970 | 30287449 | Clin Med (Lond) | Vitamin E - a cause for concern? | 2018 | Details |
A44001 | 30174510 | Saudi J Biol Sci | Effects of a medicinal plant Macrotyloma uniflorum (Lam.) Verdc.formulation (MUF) on obesity-associated oxidative stress-induced liver injury. | 2018 | Details |
A44410 | 28692197 | J Gastroenterol Hepatol | The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups. | 2018 | Details |
A44515 | 28397875 | Am J Gastroenterol | Treatment of NASH: What Helps Beyond Weight Loss? | 2017 | Details |
A44819 | 27184632 | Saudi J Gastroenterol | Is vitamin e or ursodeoxycholic acid a valid treatment option for nonalcoholic fatty liver disease in 2016? | 2016 | Details |
A44937 | 26698585 | AMA J Ethics | Enrolling Research Participants in Private Practice: Conflicts of Interest, Consistency, Therapeutic Misconception, and Informed Consent. | 2015 | Details |
A44964 | 26592819 | Eur Rev Med Pharmacol Sci | Reply to the Letter "Effect of anti-oxidant agents in patients with hepatocellular diseases". | 2015 | Details |
A44965 | 26592818 | Eur Rev Med Pharmacol Sci | Effect of anti-oxidant agents in patients with hepatocellular diseases. | 2015 | Details |
A45065 | 26206676 | Hepatology | Reply. | 2015 | Details |
A45067 | 26206460 | Hepatology | The fat droplet in hepatocellular ballooning and implications for scoring nonalcoholic steatohepatitis therapeutic response. | 2015 | Details |
A45142 | 25933502 | Nutrition | Vitamin E therapy on aminotransferase levels in NAFLD/NASH patients. | 2015 | Details |
A45143 | 25933501 | Nutrition | Vitamin E therapy for NAFLD/NASH. | 2014 | Details |
A45190 | 25763510 | JIMD Rep | Extreme Contrast of Postprandial Remnant-Like Particles Formed in Abetalipoproteinemia and Homozygous Familial Hypobetalipoproteinemia. | 2015 | Details |
A45315 | 25209117 | Hepatology | GLI2 as a marker of hedgehog-responsive cells. | 2015 | Details |
A45316 | 25209009 | Hepatology | Reply: To PMID 24849310. | 2015 | Details |
A45367 | 24975580 | Hepatology | Ballooned hepatocytes, undead cells, sonic hedgehog, and vitamin E: therapeutic implications for nonalcoholic steatohepatitis. | 2014 | Details |
A45460 | 24459637 | Clin Mol Hepatol | KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. | 2013 | Details |
A45487 | 24353344 | J Nutr | Antioxidant supplements reduced oxidative stress and stabilized liver function tests but did not reduce inflammation in a randomized controlled trial in obese children and adolescents. | 2013 | Details |
A45640 | 23495130 | Liver Transpl | High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. | 2013 | Details |
A45698 | 23236625 | Curr Opin Clin Nutr Metab Care | Bibliography. Micronutrients. Current world literature. | 2012 | Details |
A45810 | 22641309 | Am J Gastroenterol | The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. | 2012 | Details |
A45830 | 22488764 | Hepatology | The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. | 2012 | Details |
A45907 | 22149573 | Expert Rev Gastroenterol Hepatol | Medical therapy for nonalcoholic fatty liver disease in children and adolescents. | 2012 | Details |
A45939 | 21947647 | Nutr Clin Pract | Vitamin E for nonalcoholic fatty liver disease. | 2011 | Details |
A45980 | 21750513 | Nat Rev Gastroenterol Hepatol | Nonalcoholic fatty liver disease: Targeted therapy in children--what is the right way? | 2011 | Details |
A46033 | 21476908 | Expert Rev Gastroenterol Hepatol | Does vitamin E cure nonalcoholic steatohepatitis? | 2011 | Details |
A46123 | 20890896 | Hepatology | On the mechanism of action of vitamin E for nonalcoholic steatohepatitis. | 2010 | Details |
A46157 | 20672381 | Hepatology | Suggestion of a dual-functional agent for future trials in nonalcoholic fatty liver disease. | 2010 | Details |
A46181 | 20520981 | Arq Gastroenterol | The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis. | 2010 | Details |
A46364 | 19296690 | Anal Chem | In situ lipidomic analysis of nonalcoholic fatty liver by cluster TOF-SIMS imaging. | 2009 | Details |
A46396 | 19053049 | Hepatology | Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. | 2009 | Details |
A46410 | 21180527 | Therap Adv Gastroenterol | Treatment options for nonalcoholic Fatty liver disease. | 2008 | Details |
A46492 | 18277910 | J Clin Gastroenterol | Therapy for nonalcoholic fatty liver disease. | 2008 | Details |
A46507 | 18196983 | Curr Opin Lipidol | Diet and nonalcoholic fatty liver disease. | 2008 | Details |
A46590 | 17410454 | Dig Dis Sci | The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study. | 2007 | Details |
A46661 | 16771968 | Am J Gastroenterol | Metformin, vitamin E, and diet for patients with nonalcoholic fatty liver disease. | 2006 | Details |
A46674 | 16698763 | Gut | A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations. | 2006 | Details |
A46690 | 16510031 | Curr Gastroenterol Rep | New treatments for nonalcoholic fatty liver disease. | 2006 | Details |
A46697 | 16456401 | J Pediatr Gastroenterol Nutr | Clinical Research Network launches TONIC trial for treatment of nonalcoholic fatty liver disease in children. | 2006 | Details |
A46718 | 16245220 | Turk J Gastroenterol | Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. | 2005 | Details |
A46768 | 15727706 | Zhonghua Gan Zang Bing Za Zhi | [Drug therapy for nonalcoholic fatty liver disease]. | 2005 | Details |
A46860 | 12408779 | Curr Treat Options Gastroenterol | Therapeutic Options in Nonalcoholic Fatty Liver Disease. | 2002 | Details |
A47290 | 19003881 | Hepatology | Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms. | 2008 | Details |
A47412 | 8667240 | J Pharmacol Exp Ther | Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. | 1996 | Details |